US Patent Number
The present invention provides methods of delaying development of CEA-associated tumors using the anti-idiotype antibody 3H1, particularly in high-risk individuals.
University of Kentucky Research Foundation, Lexington, KY (US)
Chatterjee, Malaya; Foon, Kenneth A.; and Chatterjee, Sunil K., "Methods of Delaying Development of CEA-Associated Tumors Using Anti-Idiotype Antibody 3H1" (2007). Pharmaceutical Sciences Faculty Patents. 120.